C07C 2602/28
Hydrogenated naphthalenes
C07C2602/28 (Hydrogenated naphthalenes) appears on 287 US grants and 233 published applications in this corpus.
Search patents in C07C- Granted patents
- 287
- Published applications
- 233
- Assignees
- 202
- Inventors
- 884
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 8 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 6 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 6 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 5 |
| 2002 | 14 | 10 |
| 2003 | 7 | 19 |
| 2004 | 14 | 15 |
| 2005 | 7 | 11 |
| 2006 | 12 | 12 |
| 2007 | 8 | 10 |
| 2008 | 6 | 11 |
| 2009 | 7 | 10 |
| 2010 | 10 | 10 |
| 2011 | 4 | 14 |
| 2012 | 5 | 4 |
| 2013 | 4 | 6 |
| 2014 | 7 | 5 |
| 2015 | 5 | 6 |
| 2016 | 8 | 10 |
| 2017 | 9 | 5 |
| 2018 | 8 | 16 |
| 2019 | 11 | 6 |
| 2020 | 8 | 4 |
| 2021 | 8 | 11 |
| 2022 | 4 | 5 |
| 2023 | 4 | 6 |
| 2024 | 6 | 11 |
| 2025 | 3 | 6 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ionizable cationic lipids for RNA delivery1 Sep 2026US 12,723,023 B2Arcturus Therapeutics, Inc.
- Method for preparing intermediate for synthesis of sphingosine-1-phosphate receptor agonist13 Jan 2026US 12,522,554 B2LG Chem.Ltd.
- Processes and compounds14 Oct 2025US 12,441,745 B2Radius Pharmaceuticals, Inc.
- Method of mitigating conversion of volatile terpene species8 Jul 2025US 12,351,546 B2Givaudan SA
- Bi- and tricyclic compounds for use as aroma chemicals25 Feb 2025US 12,234,206 B2BASF SE
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Hybrid compounds of sclareol and doxorubicin, their synthesis and application25 Jun 2026US 2026/0174860 A1Institute for Biological Research "Sinisa Stankovic" - National Institute of the Republic of Serbia
- Artemisinic acid derivative, and preparation method therefor and application thereof26 Mar 2026US 2026/0085030 A1Yunnan Botanee Bio-Technology Group Co., Ltd.
- Processes and compounds8 Jan 2026US 2026/0008792 A1Radius Pharmaceuticals, Inc.
Most cited
By later US patents
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Process for preparing alcohols150US 4,317,918 ASumitomo Chemical Company, Limited · 1982
- Hydrogenated naphthalenes137US 4,391,731 AHoffmann-La Roche Inc. · 1983
- Octahydronapthalenes82US 4,499,289 AG. D. Searle & Co. · 1985
- Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application59US 5,658,962 AMinnesota Mining and Manufacturing Company · 1997